Our country did not cede the nuclear race to the Soviet Union, and we cannot cede the biotechnology race to China now.

LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed ...

As the world prepares to feed an estimated 9.7 billion people by 2050, agriculture is rapidly transforming into one of the most critical and opportunity-rich sectors of the 21st century. No longer ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...

Visionary entrepreneur and health innovator joins the movement to reverse America s chronic disease epidemic WASHINGTON, Apr. 21, 2026 /PRNewswire/ -- MAHA Action, the national organization leading ...

LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing ...

Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

UCB has agreed to acquire Candid Therapeutics for up-to-$2.2 billion, in a deal designed to expand the buyer’s presence in ...

Protein language models are artificial intelligence tools which help engineer proteins with useful properties, including ...